187 related articles for article (PubMed ID: 23698606)
21. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification by WHO of elimination of transmission in Colombia.
Wkly Epidemiol Rec; 2013 Sep; 88(36):381-5. PubMed ID: 24052954
[No Abstract] [Full Text] [Related]
22. Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.
Lustigman S; McCarter JP
PLoS Negl Trop Dis; 2007 Aug; 1(1):e76. PubMed ID: 17989789
[No Abstract] [Full Text] [Related]
23. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.
Kim YE; Remme JH; Steinmann P; Stolk WA; Roungou JB; Tediosi F
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003664. PubMed ID: 25860569
[TBL] [Abstract][Full Text] [Related]
24. Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala.
Gonzalez RJ; Cruz-Ortiz N; Rizzo N; Richards J; Zea-Flores G; Domínguez A; Sauerbrey M; Catú E; Oliva O; Richards FO; Lindblade KA
PLoS Negl Trop Dis; 2009; 3(3):e404. PubMed ID: 19333366
[TBL] [Abstract][Full Text] [Related]
25. Interruption of Onchocerca volvulus transmission in Northern Venezuela.
Convit J; Schuler H; Borges R; Olivero V; Domínguez-Vázquez A; Frontado H; Grillet ME
Parasit Vectors; 2013 Oct; 6(1):289. PubMed ID: 24499653
[TBL] [Abstract][Full Text] [Related]
26. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
27. Population biology of human onchocerciasis.
Basáñez MG; Boussinesq M
Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
[TBL] [Abstract][Full Text] [Related]
28. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
29. Progress towards eliminating onchocerciasis in the WHO Region of the Americas in 2011: interruption of transmission in Guatemala and Mexico.
Wkly Epidemiol Rec; 2012 Aug; 87(33):309-14. PubMed ID: 22905372
[No Abstract] [Full Text] [Related]
30. Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus.
Botto C; Basañez MG; Escalona M; Villamizar NJ; Noya-Alarcón O; Cortez J; Vivas-Martínez S; Coronel P; Frontado H; Flores J; Graterol B; Camacho O; Tovar Y; Borges D; Morales AL; Ríos D; Guerra F; Margeli H; Rodriguez MA; Unnasch TR; Grillet ME
Parasit Vectors; 2016 Jan; 9():40. PubMed ID: 26813296
[TBL] [Abstract][Full Text] [Related]
31. Onchocerciasis.
Taylor HR
Int Ophthalmol; 1990 May; 14(3):189-94. PubMed ID: 2188920
[TBL] [Abstract][Full Text] [Related]
32. [Onchocerciasis].
Enk CD; Gardlo K; Ruzicka T; BenEzra D
Hautarzt; 2003 Jun; 54(6):513-7. PubMed ID: 12759735
[TBL] [Abstract][Full Text] [Related]
33. From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
Colebunders R; Siewe Fodjo JN; Hopkins A; Hotterbeekx A; Lakwo TL; Kalinga A; Logora MY; Basáñez MG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007407. PubMed ID: 31318857
[No Abstract] [Full Text] [Related]
34. Report from the Inter-American Conference on Onchocerciasis, November 2007.
Wkly Epidemiol Rec; 2008 Jul; 83(29):256-60. PubMed ID: 18637266
[No Abstract] [Full Text] [Related]
35. The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
Abong RA; Amambo GN; Hamid AA; Enow BA; Beng AA; Nietcho FN; Nji TM; Njouendou AJ; Ritter M; Esum ME; Deribe K; Cho JF; Fombad FF; Enyong PI; Poole C; Pfarr K; Hoerauf A; Carlow C; Wanji S
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008926. PubMed ID: 33465080
[TBL] [Abstract][Full Text] [Related]
36. Onchocerciasis (river blindness) - more than a century of research and control.
Brattig NW; Cheke RA; Garms R
Acta Trop; 2021 Jun; 218():105677. PubMed ID: 32857984
[TBL] [Abstract][Full Text] [Related]
37. River blindness: a success story under threat?
Basáñez MG; Pion SD; Churcher TS; Breitling LP; Little MP; Boussinesq M
PLoS Med; 2006 Sep; 3(9):e371. PubMed ID: 17002504
[TBL] [Abstract][Full Text] [Related]
38. Final report of the Conference on the eradicability of Onchocerciasis.
Dadzie Y; Neira M; Hopkins D
Filaria J; 2003 Feb; 2(1):2. PubMed ID: 12605722
[TBL] [Abstract][Full Text] [Related]
39. Onchocerca volvulus: The Road from Basic Biology to a Vaccine.
Lustigman S; Makepeace BL; Klei TR; Babayan SA; Hotez P; Abraham D; Bottazzi ME
Trends Parasitol; 2018 Jan; 34(1):64-79. PubMed ID: 28958602
[TBL] [Abstract][Full Text] [Related]
40. Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?
Frempong KK; Walker M; Cheke RA; Tetevi EJ; Gyan ET; Owusu EO; Wilson MD; Boakye DA; Taylor MJ; Biritwum NK; Osei-Atweneboana M; Basáñez MG
Clin Infect Dis; 2016 Jun; 62(11):1338-1347. PubMed ID: 27001801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
